Robert F. Apple, President & CEO at ANTARES PHARMA, INC. (ATRS), sold 172,684 shares at $4.75 ($820K) on 2021-02-08, disclosed to the SEC on 2021-02-10.
Seasonal sale ($820k) by President & CEO — this insider has traded ATRS in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.75 | 33,574 | $159K | 19.4% |
| 2 | $4.75 | 33,574 | $159K | 19.4% |
| 3 | $4.75 | 49,129 | $233K | 28.5% |
| 4 | $4.75 | 49,129 | $233K | 28.5% |
| 5 | $4.75 | 7,278 | $35K | 4.2% |
| Total | $4.75 avg | 172,684 |
| $820K |
| 100% |
| Filing → |
| ATRS | SELL | 2018-08-23 | $161K | — | Filing → |
| ATRS | SELL | 2017-04-05 | $120K | — | Filing → |
| ATRS | BUY | 2016-03-18 | $43K | — | Filing → |